Unraveling the epidemiology of metabolic dysfunction-associated liver cancer: Insights from mixed etiologies, regional variations, and gender disparities.
作者信息
Feng Gong, Fan Ya-Fei, Li Ru-Xin, Targher Giovanni, Byrne Christopher D, Zheng Ming-Hua
机构信息
Institute of General Practice, Xi'an Medical University, Xi'an 710021, China.
Department of Infectious Disease, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
出版信息
ILIVER. 2024 Aug 14;3(3):100113. doi: 10.1016/j.iliver.2024.100113. eCollection 2024 Sep.
Abstract
摘要
相似文献
1
Unraveling the epidemiology of metabolic dysfunction-associated liver cancer: Insights from mixed etiologies, regional variations, and gender disparities.解析代谢功能障碍相关肝癌的流行病学：来自混合病因、地区差异和性别差异的见解
ILIVER. 2024 Aug 14;3(3):100113. doi: 10.1016/j.iliver.2024.100113. eCollection 2024 Sep.
2
Global Trend of MASH-associated Liver Cancer: A Systematic Analysis From the Global Burden of Disease 2021.与MASH相关的肝癌全球趋势：来自《2021年全球疾病负担》的系统分析
Clin Gastroenterol Hepatol. 2025 Jul;23(8):1346-1355. doi: 10.1016/j.cgh.2024.10.026. Epub 2024 Dec 16.
3
Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease: Mapping Across Different Indian Populations (MAP Study).代谢功能障碍相关脂肪性肝病的患病率：印度不同人群的图谱研究（MAP研究）
Diabetes Ther. 2025 May 17. doi: 10.1007/s13300-025-01748-1.
4
Trends and future projections of liver cancer attributable to metabolic dysfunction-associated steatohepatitis in China from 1990 to 2050.1990年至2050年中国代谢功能障碍相关脂肪性肝炎所致肝癌的趋势及未来预测
Sci Rep. 2025 Jul 2;15(1):23255. doi: 10.1038/s41598-025-06617-2.
5
Global, Regional, and National Burden and Trends of Soft Tissue and Other Extraosseous Sarcomas From 1990 to 2021.1990年至2021年全球、区域和国家软组织及其他骨外肉瘤的负担与趋势
Cancer Control. 2025 Jan-Dec;32:10732748251355841. doi: 10.1177/10732748251355841. Epub 2025 Jun 28.
6
Global, regional and national burden of Metabolic dysfunction-associated steatotic liver disease in adolescents and adults aged 15-49 years from 1990 to 2021: results from the 2021 Global Burden of Disease study.1990年至2021年15至49岁青少年和成年人中代谢功能障碍相关脂肪性肝病的全球、区域和国家负担：2021年全球疾病负担研究结果
Front Med (Lausanne). 2025 Jun 25;12:1568211. doi: 10.3389/fmed.2025.1568211. eCollection 2025.
7
Do Patients of Different Levels of Affluence Receive Different Care for Pediatric Osteosarcomas? One Institution's Experience.不同富裕程度的患者在小儿骨肉瘤治疗上是否得到不同的护理？一家机构的经验。
Clin Orthop Relat Res. 2025 Apr 1;483(4):748-758. doi: 10.1097/CORR.0000000000003299. Epub 2024 Oct 30.
8
A systematic review of geographical differences in management and outcomes for colorectal cancer in Australia.澳大利亚结直肠癌管理与治疗结果的地理差异系统评价。
BMC Cancer. 2017 Feb 2;17(1):95. doi: 10.1186/s12885-017-3067-1.
9
Global burden and trend of stroke attributable to metabolic risks among young adults (20-39 years old) from 1990 to 2021.1990年至2021年期间，20至39岁年轻成年人中代谢风险所致中风的全球负担及趋势。
Front Cardiovasc Med. 2025 Jun 2;12:1561052. doi: 10.3389/fcvm.2025.1561052. eCollection 2025.
10
Global epidemiological trends in prostate cancer burden: a comprehensive analysis from Global Burden of Disease Study 2021.前列腺癌负担的全球流行病学趋势：来自《2021年全球疾病负担研究》的综合分析
Transl Androl Urol. 2025 May 30;14(5):1238-1252. doi: 10.21037/tau-2025-103. Epub 2025 May 27.
本文引用的文献
1
Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study.代谢功能障碍相关脂肪性肝病和/或酒精所致肝癌风险：一项全国性研究
Am J Gastroenterol. 2025 Feb 1;120(2):410-419. doi: 10.14309/ajg.0000000000002920. Epub 2024 Jun 27.
2
Recompensation in MASLD-related cirrhosis via metabolic bariatric surgery.代谢性减重手术对非酒精性脂肪性肝病相关肝硬化的代偿作用
Trends Endocrinol Metab. 2025 Feb;36(2):118-132. doi: 10.1016/j.tem.2024.05.009. Epub 2024 Jun 21.
3
Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis.全球代谢功能障碍相关脂肪性肝病相关肝细胞癌的患病率：系统评价和荟萃分析。
Clin Mol Hepatol. 2024 Jul;30(3):436-448. doi: 10.3350/cmh.2024.0109. Epub 2024 Apr 16.
4
Sex differences in mortality and liver-related events in non-alcoholic fatty liver disease: A systematic review and meta-analysis.非酒精性脂肪性肝病患者的死亡率和肝脏相关事件的性别差异：系统评价和荟萃分析。
Liver Int. 2024 Jul;44(7):1600-1609. doi: 10.1111/liv.15910. Epub 2024 Mar 20.
5
Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future.代谢功能障碍相关脂肪性肝病与肝细胞癌：现状与未来
Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):945-948. doi: 10.21037/hbsn-23-539. Epub 2023 Nov 15.
6
Letter: Detecting unreported alcohol consumption in patients with NAFLD-Standardisation is urgent.信函：检测非酒精性脂肪性肝病患者未报告的酒精摄入量——标准化迫在眉睫。
Aliment Pharmacol Ther. 2023 Nov;58(9):967-968. doi: 10.1111/apt.17723.
7
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease.肝硬化的代偿：揭开非酒精性脂肪性肝病的自然史演变。
Nat Rev Gastroenterol Hepatol. 2024 Jan;21(1):46-56. doi: 10.1038/s41575-023-00846-4. Epub 2023 Oct 5.
8
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.全球、地区和国家 1990 年至 2021 年糖尿病负担，以及对 2050 年患病率的预测：2021 年全球疾病负担研究的系统分析。
Lancet. 2023 Jul 15;402(10397):203-234. doi: 10.1016/S0140-6736(23)01301-6. Epub 2023 Jun 22.
Zotero 插件